Endocrine Disruptors: Assessment of endocrine disruption activity, mechanism and
Endocrine Disruptors: Assessment of endocrine disruption activity, mechanism and
批准号:
7940433
负责人:
Subhrangsu S Mandal
金额:
$44.49万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-10 至 2013-09-30
关键词:
Adverse effectsAnimalsAssesAwarenessBehaviorBindingBiochemicalBiochemistryBiological AssayBreastCause of DeathCellsChemicalsChromatinCommunitiesCommunity OutreachDevelopmentDiseaseEmbryonic DevelopmentEndocrine DisruptorsEndocrine disruptionEnvironmental Risk FactorEnzymesEpigenetic ProcessEstradiolEstrogen Receptor alphaEstrogen ReceptorsEstrogensFamilyFoodFood HabitsGene ActivationGene ExpressionGene Expression RegulationGenesGeneticGenital systemGeographic LocationsHairHandHealthHistonesHomeobox GenesHormonalHormonesHumanIncidenceKnowledgeLaboratoriesLearningLifeMalignant NeoplasmsMalignant neoplasm of prostateMediatingPesticidesPlasticsProcessRegulationRelative (related person)ReproductionResponse ElementsRiskRunningSequence AnalysisServicesSignal TransductionSkeletal DevelopmentSocietiesSourceSyndromeTranscriptional RegulationTransferaseUnited Statesbasechromatin modificationdrinking waterfoothuman diseasein vivoinsightleukemianoveloutreachparalogous genepromoterpublic health relevancereceptor bindingresearch studysteroid hormone
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cancer is a major cause of death in United States and around the world. Numerous studies suggest that in addition to genetic factors, environmental factors, food habit and geographic location have significant contribution to the rate of cancer incidence. Among the environmental factors Endocrine Disrupting Chemicals (EDCs) appear to be a major contributor towards several human diseases including cancer. EDCs are family of chemicals that mimic hormones and interfere with normal hormonal functions resulting in adverse effects on human and animal health. Sources of EDCs may include daily foods, drinking water, plastics, pesticides, synthetic hormones etc. Although EDCs are major health concern, knowledge is still limited in terms of their endocrine disruption activity, mechanism of action and health risk. Based on our expertise on estrogen signaling, gene regulation and epigenetics biochemistry, we proposed to a) asses the endocrine disruption activity of various known and unknown EDCs, b) understand their mechanism of action and c) outreach to the community to increase the awareness about EDCs. In order to develop assays for the analysis of EDC activity, we propose to utilize the promoter of estrogen responsive HOX genes that are key players in embryonic development. Recently, we found that estrogen (E2) transcriptionally regulates several HOX genes including HOXC13 and paralogous genes (HOXA13, B13 and D13). HOXC13 promoter contains multiple estrogen response elements (EREs) to which estrogen receptors (ER: ERa and ER¿) bind during E2-mediated gene activation. Importantly, we also found that mixed lineage leukemia (MLL) family of histone methyl-transferases that are crucial players in gene activation, interact with ERs and bind to these EREs to regulate HOXC13 expression in presence of E2. Based on these findings, we hypothesize that HOXC13 and paralogous genes are regulated by ERs and MLLs (as coregulators). Herein, we propose to investigate the epigenetic regulatory mechanisms of E2-mediated transcriptional regulation of HOXC13 and paralogous genes and expand this knowledge to develop novel cell based assays to assess the endocrine disruption activity of various known and unknown EDCs and understand their mechanisms of action. In addition, we also propose to outreach to the community (through service learning) to increase awareness about EDCs. These studies will unfold the epigenetic regulatory mechanism of E2- mediated regulation of HOX genes. In addition, these studies will provide novel insights about the action of EDCs and also provide novel assays to assess the endocrine disruption activities of various known and unknown EDCs. The outreach activity will increase the local community awareness about EDCs and their relevance to human health and society that will have high impact on quality of human health, and may reduce the incidence of cancer and other diseases.
PUBLIC HEALTH RELEVANCE: Endocrine Disrupting Chemicals (EDCs) are family of chemicals that mimic hormones and interfere with normal hormonal functions resulting in adverse effects on reproduction, behavior and development ultimately causing severe human diseases including cancer. Herein, experiments are proposed to a) asses the endocrine disruption activity of various known and unknown EDCs, b) understand their mechanism of action and c) outreach to the community to increase the awareness about EDCs. These studies will have high impact on quality of human life, health and may reduce the incidence of cancer and other diseases in long run.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.bbcan.2015.07.001
发表时间:
2015-08
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
[Bhan A, Mandal SS]
通讯作者:
Mandal SS
DOI:
10.1158/0008-5472.can-16-2634
发表时间:
2017-08-01
期刊:
Cancer research
影响因子:
11.2
作者:
[Bhan A, Soleimani M, Mandal SS]
通讯作者:
Mandal SS
DOI:
10.1039/c2ra22006g
发表时间:
2013-01-01
期刊:
RSC advances
影响因子:
3.9
作者:
[Kasiri S, Ansari KI, Hussain I, Bhan A, Mandal SS]
通讯作者:
Mandal SS
DOI:
10.1016/j.bbagrm.2015.02.003
发表时间:
2015-06
期刊:
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS
影响因子:
4.7
作者:
[Hussain, Imran, Bhan, Arunoday, Ansari, Khairul I., Deb, Paromita, Bobzean, Samara A. M., Perrotti, Linda I., Mandal, Subhrangsu S.]
通讯作者:
Mandal, Subhrangsu S.
DOI:
10.1038/onc.2012.352
发表时间:
2013-07-11
期刊:
ONCOGENE
影响因子:
8
作者:
[Ansari, K. I., Kasiri, S., Mandal, S. S.]
通讯作者:
Mandal, S. S.
共 13 条
IDO1 regulation of SR-BI and cholesterol homeostasis in macrophages
-
批准号:10731003
-
项目类别:
-
资助金额:$45.75万
-
财政年份:2023
-
负责人:Subhrangsu S Mandal
-
依托单位:
Roles of MLL histone methyalses in estrogen mediated regulation of HDLR-SRB1
-
批准号:7882188
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2010
-
负责人:Subhrangsu S Mandal
-
依托单位:
海外基金